Dacomitinib
Category: CancerDacomitinib Overview
Dacomitinib, sold under the brand name Vizimpro, is a medication for the treatment of non-small-cell lung carcinoma (NSCLC). It is a selective and irreversible inhibitor of EGFR.[1] Dacomitinib has advanced to several Phase III clinical trials.[when?] The January 2014 results of the first trials were disappointing, with a failure to meet the study goals.[2][3][4] Additional Phase III trials are ongoing[...
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Dacomitinib
Recent Dacomitinib Forums:
Be the first to start a discussion about this drug.Possible Dosages for this and Related Drugs:
Dacomitinib
- Tablet: 15mg, 30mg, 45mg
Other drugs which contain Dacomitinib or a similar ingredient: (1 result)
- VIZIMPRO Dacomitinib